MALVERN, PA and SAINT-PREX, SWITZERLAND--(Marketwire - December 01, 2008) - Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Ferring International S.A. today announced an exclusive agreement between them for the European distribution and license rights to Testim®, a proprietary, topical 1% testosterone once-a-day gel indicated for the treatment of hypogonadism.
